Revance Therapeutics Inc (NASDAQ:RVNC)

Delayed Data
As of 3:59pm ET
 +0.13 / +0.40%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 13 analysts offering 12-month price forecasts for Revance Therapeutics Inc have a median target of 39.00, with a high estimate of 65.00 and a low estimate of 20.00. The median estimate represents a +20.89% increase from the last price of 32.26.

Analyst Recommendations

The current consensus among 13 polled investment analysts is to Buy stock in Revance Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -12.96%
Growthannually 18.61%


Growthquarterly -8.40%
Growthannually 78.75%
Key to the earnings and sales forecast charts.